Adage Capital Partners’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.3M Sell
350,000
-1,375,000
-80% -$74.6M 0.03% 462
2025
Q4
$79.6M Buy
1,725,000
+1,392,000
+418% +$62.3M 0.12% 166
2025
Q3
$12M Buy
+333,000
New +$11M 0.02% 598
2024
Q3
Sell
-85,088
Closed -$6.42M 922
2024
Q2
$6.42M Hold
85,088
0.01% 682
2024
Q1
$5.81M Sell
85,088
-65,000
-43% -$4.5M 0.01% 681
2023
Q4
$9.43M Buy
150,088
+18,000
+14% +$935K 0.02% 603
2023
Q3
$6.73M Buy
132,088
+72,000
+120% +$3.55M 0.02% 629
2023
Q2
$3M Sell
60,088
-374,912
-86% -$17.8M 0.01% 717
2023
Q1
$16.3M Sell
435,000
-360,000
-45% -$15.3M 0.04% 487
2022
Q4
$38.1M Buy
795,000
+695,000
+695% +$27.3M 0.09% 257
2022
Q3
$2.4M Buy
100,000
+47,100
+89% +$1.19M 0.01% 843
2022
Q2
$1.15M Buy
+52,900
New +$1.22M ﹤0.01% 916

Other funds holding PCVX